MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with M

Mirtazapine

Mirtazapine 2mg capsules

No stability information

Stability notes for Mirtazapine 2mg capsules

There are no stability notes for this medicine.

Supplier

Mirtazapine 2mg capsules (Special Order)

Mirtazapine 4mg capsules

No stability information

Stability notes for Mirtazapine 4mg capsules

There are no stability notes for this medicine.

Supplier

Mirtazapine 4mg capsules (Special Order)

Mirtazapine 15mg orodispersible tablets

Incompatible

Stability notes for Mirtazapine 15mg orodispersible tablets

Formulation not suitable for use in MCAs.  Very moisture sensitive medicine. Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products mirtazapine 15mg, 30mg and 45mg orodispersible tablets (Accord Healthcare Limited) and mirtazapine 15mg, 30mg and 45mg orodispersible tablets (Krka UK Ltd).

Suppliers (9) of Mirtazapine 15mg orodispersible tablets
Mirtazapine 15mg orodispersible tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 15mg orodispersible tablets (Accord-UK Ltd)
Mirtazapine 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 15mg orodispersible tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 15mg orodispersible tablets (Medihealth (Northern) Ltd)
Mirtazapine 15mg orodispersible tablets (Medreich Plc)
Mirtazapine 15mg orodispersible tablets (Milpharm Ltd)
Mirtazapine 15mg orodispersible tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 15mg orodispersible tablets (Sigma Pharmaceuticals Plc)

Mirtazapine 15mg tablets

Use with caution

Stability notes for Mirtazapine 15mg tablets

Protect from moisture. Manufacturer recommends storing in original container. No stability data in MCAs available Anecdotal reports of use in MCAs for up to 7 days (low quality evidence)

Provenance

This recommendation is based on the products mirtazapine 15mg film-coated tablets (Accord Healthcare Limited) and mirtazapine 15mg film-coated tablets (Amarox Limited).

Suppliers (15) of Mirtazapine 15mg tablets
Mirtazapine 15mg tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 15mg tablets (AAH Hillcross)
Mirtazapine 15mg tablets (Accord-UK Ltd)
Mirtazapine 15mg tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 15mg tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 15mg tablets (Amarox Ltd)
Mirtazapine 15mg tablets (Genesis Pharmaceuticals Ltd)
Mirtazapine 15mg tablets (Manx Healthcare Ltd)
Mirtazapine 15mg tablets (Medihealth (Northern) Ltd)
Mirtazapine 15mg tablets (Medreich Plc)
Mirtazapine 15mg tablets (Milpharm Ltd)
Mirtazapine 15mg tablets (Noumed Life Sciences Ltd)
Mirtazapine 15mg tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 15mg tablets (Relonchem Ltd)
Mirtazapine 15mg tablets (Sigma Pharmaceuticals Plc)

Mirtazapine 30mg orodispersible tablets

Incompatible

Stability notes for Mirtazapine 30mg orodispersible tablets

Formulation not suitable for use in MCAs.  Very moisture sensitive medicine. Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products mirtazapine 15mg, 30mg and 45mg orodispersible tablets (Accord Healthcare Limited) and mirtazapine 15mg, 30mg and 45mg orodispersible tablets (Krka UK Ltd).

Suppliers (8) of Mirtazapine 30mg orodispersible tablets
Mirtazapine 30mg orodispersible tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 30mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 30mg orodispersible tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 30mg orodispersible tablets (Medihealth (Northern) Ltd)
Mirtazapine 30mg orodispersible tablets (Medreich Plc)
Mirtazapine 30mg orodispersible tablets (Milpharm Ltd)
Mirtazapine 30mg orodispersible tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 30mg orodispersible tablets (Sigma Pharmaceuticals Plc)

Mirtazapine 30mg tablets

Use with caution

Stability notes for Mirtazapine 30mg tablets

Protect from moisture. Manufacturer recommends storing in original container. No stability data in MCAs available Anecdotal reports of use in MCAs for up to 7 days (low quality evidence)

Provenance

This recommendation is based on the products mirtazapine 30mg film-coated tablets (Accord Healthcare Limited) and mirtazapine 30mg film-coated tablets (Amarox Limited).

Suppliers (20) of Mirtazapine 30mg tablets
Mirtazapine 30mg tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 30mg tablets (AAH Hillcross)
Mirtazapine 30mg tablets (Accord-UK Ltd)
Mirtazapine 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 30mg tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 30mg tablets (Amarox Ltd)
Mirtazapine 30mg tablets (Austin McNeil Ltd)
Mirtazapine 30mg tablets (Crescent Pharma Ltd)
Mirtazapine 30mg tablets (Ennogen Healthcare International Ltd)
Mirtazapine 30mg tablets (Flamingo Pharma (UK) Ltd)
Mirtazapine 30mg tablets (Genesis Pharmaceuticals Ltd)
Mirtazapine 30mg tablets (Manx Healthcare Ltd)
Mirtazapine 30mg tablets (Medihealth (Northern) Ltd)
Mirtazapine 30mg tablets (Medreich Plc)
Mirtazapine 30mg tablets (Milpharm Ltd)
Mirtazapine 30mg tablets (Noumed Life Sciences Ltd)
Mirtazapine 30mg tablets (Novumgen Ltd)
Mirtazapine 30mg tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 30mg tablets (Relonchem Ltd)
Mirtazapine 30mg tablets (Sigma Pharmaceuticals Plc)

Mirtazapine 45mg orodispersible tablets

Incompatible

Stability notes for Mirtazapine 45mg orodispersible tablets

Formulation not suitable for use in MCAs.  Very moisture sensitive medicine. Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products mirtazapine 45mg orodispersible tablets (Accord Healthcare Limited) and mirtazapine 45mg orodispersible tablets (Krka UK Ltd).

Suppliers (8) of Mirtazapine 45mg orodispersible tablets
Mirtazapine 45mg orodispersible tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 45mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 45mg orodispersible tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 45mg orodispersible tablets (Medihealth (Northern) Ltd)
Mirtazapine 45mg orodispersible tablets (Medreich Plc)
Mirtazapine 45mg orodispersible tablets (Milpharm Ltd)
Mirtazapine 45mg orodispersible tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 45mg orodispersible tablets (Sigma Pharmaceuticals Plc)

Mirtazapine 45mg tablets

Use with caution

Stability notes for Mirtazapine 45mg tablets

Protect from moisture. Manufacturer recommends storing in original container. No stability data in MCAs available Anecdotal reports of use in MCAs for up to 7 days (low quality evidence).

Provenance

This recommendation is based on the products mirtazapine 45mg film-coated tablets (Accord Healthcare Limited) and mirtazapine 45mg film-coated tablets (Amarox Limited).

Suppliers (14) of Mirtazapine 45mg tablets
Mirtazapine 45mg tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 45mg tablets (Accord-UK Ltd)
Mirtazapine 45mg tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 45mg tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 45mg tablets (Amarox Ltd)
Mirtazapine 45mg tablets (Genesis Pharmaceuticals Ltd)
Mirtazapine 45mg tablets (Manx Healthcare Ltd)
Mirtazapine 45mg tablets (Medihealth (Northern) Ltd)
Mirtazapine 45mg tablets (Medreich Plc)
Mirtazapine 45mg tablets (Milpharm Ltd)
Mirtazapine 45mg tablets (Noumed Life Sciences Ltd)
Mirtazapine 45mg tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 45mg tablets (Relonchem Ltd)
Mirtazapine 45mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.